Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Spinal cord dynorphin precursor intermediates decline during late gestation

V M Medina1, D Gupta, A R Gintzler

  • 1Department of Biochemistry, State University of New York Health Science Center at Brooklyn 11203, USA.

Journal of Neurochemistry
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitamin D and prostate cancer risk: a review of the epidemiological literature.

Prostate cancer and prostatic diseases·2009
Same author

Hodgkin lymphoma involving ascending colon and mesenteric lymphnodes: A rare entity.

Indian journal of cancer·2009
Same author

In utero exposure to methyl isocyanate in the Bhopal gas disaster: evidence of persisting hyperactivation of immune system two decades later.

Occupational and environmental medicine·2009
Same author

Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass.

Diabetologia·2009
Same author

Primary testicular non-Hodgkin lymphoma: a single institution experience from India.

Indian journal of cancer·2009
Same author

Pleural effusion in acute myeloid leukemia.

The Journal of the Association of Physicians of India·2009

Maternal pain relief during pregnancy involves a spinal cord dynorphin system. Increased processing of dynorphin precursors suggests adaptation to pregnancy demands.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Reproductive Biology

Background:

  • Pregnancy and childbirth involve maternal analgesia, partly mediated by the spinal cord dynorphin/kappa opioid system.
  • This system shows increased dynorphin peptides (1-17 and 1-8) in the lumbar spinal cord during this period.

Purpose of the Study:

  • To investigate the role of dynorphin precursor processing in maternal analgesia during pregnancy.
  • To quantify changes in dynorphin precursor intermediates and mature peptides in the spinal cord.

Main Methods:

  • Measurement of trypsin-generated arginine6-leucine-enkephalin (Leu-Enk-Arg) to reflect dynorphin precursor intermediates.
  • Quantification of dynorphin peptides (1-17 and 1-8) in spinal cord tissue.
  • Comparison of precursor and peptide levels in pregnant versus non-pregnant states.

Related Experiment Videos

Main Results:

  • Dynorphin precursor content in spinal tissue is at least 10-fold higher than mature dynorphin A (1-17) or dynorphin (1-8).
  • By gestational day 22, dynorphin precursor content significantly decreases (approx. 50%).
  • The reduction in precursor intermediates exceeds the increase in mature peptides, suggesting enhanced release.

Conclusions:

  • Enhanced processing of dynorphin precursor intermediates is an early biochemical adaptation in spinal dynorphin neurons during pregnancy.
  • This adaptation likely contributes to the maternal opioid analgesia observed during pregnancy and parturition.